Home
Careers
Conferences
Directory
Drug Discovery
Genes
InDepth
Marketing
News
Reports
Videos
Search
Contact
Items Ordered:
Cart Value:
New Products:
1.
Virtual Pharma - the radical route to success
2.
Manufacturing in the Global Pharmaceuticals Industry Key drivers, company strategies and regulations (3rd Edition)
3.
The Global Vaccines Market 2008-2023
4.
Global Biotech Market Analysis and Forecasts, 2008-2023
5.
Ablation Technologies Worldwide Market, 2008-2017: Products, Technologies Markets, Companies and Opportunities
6.
Picture Archiving and Communications Systems (PACS)
7.
Microarray Markets
8.
Medical Nanotechnology Markets
9.
Contract Manufacturing Opportunities in High-Growth Medical Devices (Catheters, Pacemakers, LVADs, Hip and Knee Implants, Air Pathways, Syringes)
10.
Infusion Pump Markets (Large Volume, Ambulatory, Disposable, Syringe, and Specialty Infusion Pumps)
Best Sellers:
1.
BioNewsCast Press Release Distribution Service
2.
5th Annual Report and Survey of Biopharmaceutical Manufacturing Capacity and Production, March 2008
3.
Peripheral Neuropathy and Neuropathic Pain, 2008
4.
Blood Glucose Testing and Diabetes Management Report
5.
The Global Antibacterials Market R&D Pipelines Market Analysis and Competitive Landscape
6.
Contract Research Annual Review 2008
7.
Good Manufacturing Practice (GMP) Course
8.
Good Clinical Practice I (GCP) course
The China Pharmaceutical Market A Strategic Opportunity Analysis
China has become an attractive destination for R&D as new opportunities have emerged following its WTO (World Trade Organization) accession. Development has accelerated both industrially and scientifically, and today the Chinese pharmaceutical market is worth around $US12 billion.
Factors fuelling the developmental growth and attracting foreign investors to the area include low labor costs, high quality clinical data and an abundance of R&D collaborative opportunities and facilities.
Global biotechnology within China has also undergone significant growth, promising enormous potential for new companies. Biotechnology companies in the country have already grown quicker than pharmaceutical companies.
The report discusses the whole of the Chinese pharmaceutical market, taking readers through the history and current state of the healthcare system through to the regulations governing the country and its growing R&D capabilities. Detailing the driving forces behind the pharma market and including a full breakdown of the biopharma opportunities, including the contacts of active Chinese companies, the report is an essential resource to understand and access this lucrative market.
Reasons to purchase this report:
Identify key partners
Assess the current market opportunity
Learn how newly implemented government changes have altered the face of the industry
Understand the organization and success of clinical trials in China
Create strategies for profitable market access into China
The Chinese government also plays an instrumental role in the pharmaceutical development of China. The introduction of WTO guidelines and protection for intellectual property rights has caused a shift in the company structures of China, forcing some to close business or enter into new collaborations.
Ideally suited for individuals wishing to introduce their companies into this emerging market or review the opportunities available, this report provides a perfect resource to identify the current pattern of the market and understand the regulations that operate within the country.
100 pages
Published Jan 2007
PDF Format
Table of Contents
Price: $1,200.00 / GBP660.00
Buy Biotechnology Management Reports online with BioPortfolio's secure E-Commerce portal.